Covid-19: Anti-TNF drug adalimumab to be trialled for patients in the community. Mahase E. BMJ 2020;371:m3847.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mahase E. Covid-19: Anti-TNF drug adalimumab to be trialled for patients in the community. BMJ 2020;371:m3847.
PMID: 33004419